Vusix, a supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced it is partnering with VSee, San Jose-based telemedicine company, to provide a smart glasses telemedicine solution for real-time video. Adding HIPAA-compliant live video chat to the Vuzix smart glasses line means real-time video doctor visits, surgical training, medical equipment training, and more.
VSee provides a HIPAA-compliant video telehealth and telemedicine video conferencing solution that is used by more than 1,000 telemedicine companies operating all over the globe, including MDLIVE, Walgreens, McKesson, International SOS and DaVita, as well as numerous A-list healthcare systems such as Ascension, HealthPartners, Sutter, Trinity and Sentara. Vusix has been developing developing immersive head mounted displays for Virtual Reality and video gaming application since the mid-1990’s. The commercial Vuzix Blade launched at CES 2019 for $999.
VSee will be showcasing the smart glasses telehealth and telemedicine solution on the Vuzix M300XL and Vuzix Blade at the American Telemedicine Association (ATA) 2019 annual conference and expo in New Orleans
Impact of Collaboration
“While VSee previously worked with some early generation smart glasses solutions, the technology was not ready for telemedicine. We feel very privileged now to be partnering with Vuzix with its mature smart glasses offerings. Telemedicine video conferencing through smart glasses from Vuzix is a natural progression from tablets and computers for our customers. We are excited to begin realizing telehealth smart glasses applications from remote training on imaging technology (CTs, ultrasounds) and inserting IVs to telesurgery to AR-enhanced video visits. We look forward to continued collaboration between our two companies,” said Milton Chen, Chief Executive Officer at VSee.
Commercial Availability
The VSee telehealth and telemedicine solution for the Vuzix M300XL and Vuzix Blade Smart Glasses is expected to be commercially available during the second quarter of 2019.
